Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

80
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
80
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

87
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

74
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
74
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

80
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
80
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

43
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
43
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

69
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral anticoagulation in patients with atrial fibrillation in Primary Care in Spain. Rationale, design and baseline data of the RACOVIR study.

Semergen·2026
Same author

Increased expression of Toll-like receptors and associated alarmins in temporal arteries of patients with giant cell arteritis.

Molecular medicine (Cambridge, Mass.)·2025
Same author

[Hydration and natural mineral water: a review on the importance of water and mineral intake for health].

Semergen·2024
Same author

Executive summary on the optimization of the multidisciplinary and integrated approach to polymyalgia rheumatica and giant cell arteritis in Madrid region.

Revista clinica espanola·2023
Same author

Home blood pressure self-measurement: "Current situation and new perspectives".

Hipertension y riesgo vascular·2022
Same author

Clinical practice in giant cell arteritis based on a survey of specialists.

Revista clinica espanola·2021

Related Experiment Video

Updated: Nov 2, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.4K

[Giant Cell Arteritis. Recommendations in Primary Care].

M Frías-Vargas1, A C Aguado-Castaño2, C Robledo-Orduña3

  • 1Centro de Salud Comillas, Madrid, España.

Semergen
|June 11, 2021
PubMed
Summary

Giant cell arteritis (GCA) is a medical emergency requiring prompt diagnosis and treatment in primary care to improve patient outcomes. This guide offers recommendations for a multidisciplinary approach to managing GCA effectively.

Keywords:
Arteritis de células gigantesAtención primariaDiagnosisDiagnósticoGiant cell arteritisPrimary careTratamientoTreatment

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

494
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

599

Related Experiment Videos

Last Updated: Nov 2, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.4K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

494
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

599

Area of Science:

  • Rheumatology
  • Vascular Medicine
  • Primary Care Medicine

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis affecting large and medium-sized arteries.
  • Significant intra and extracranial involvement in GCA necessitates urgent medical attention.
  • Early diagnosis and treatment are crucial for improving prognosis and preventing complications.

Framework:

  • Recommendations for a multidisciplinary approach to GCA management.
  • Evidence-based guidelines for primary care physicians.
  • Focus on early detection and timely intervention strategies.

Implementation:

  • Proposed by the working group on vascular diseases of SEMERGEN (Spanish Society of Primary Care Physicians).
  • Aimed at enhancing primary care's role in GCA diagnosis and treatment.
  • Facilitating coordinated patient follow-up.

Implications:

  • Improved patient outcomes through timely and effective GCA management.
  • Standardized approach to GCA care in primary care settings.
  • Reduced morbidity and mortality associated with giant cell arteritis.